Ads
related to: global pharma- Healthcare ETF
Direxion Daily Healthcare ETF
Bull 3X Shares ETF - CURE
- Bull & Bear 3X ETFs
Fixed Income, International Equity
Market Cap And Sector Equity
- ETF Education
View Our Educational Library to
Learn More About Our Products.
- ETF Line-up
View Direxion's Complete List of
Leveraged and Inverse ETFs.
- Healthcare ETF
Search results
Q1 2024 United Therapeutics Corp Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 1 minute agoNote that Pat Poisson and I will present in a fireside chat session and one-on-one meetings at the Goldman Sachs Global Healthcare Conference on June 12 in Miami. Also, our ...
Allspring Global Investments Holdings LLC Buys 1,191 Shares of UroGen Pharma Ltd. (NASDAQ:URGN)
ETF DAILY NEWS· 2 days agoAllspring Global Investments Holdings LLC lifted its stake in UroGen Pharma Ltd. (NASDAQ:URGN – Free Report) by 31.6% in the 4th quarter, according to the ...
Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop...
WTNH-TV New Haven· 3 hours agoAstellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Poseida Therapeutics, Inc. (NASDAQ: PSTX, President and CEO: Kristin Yarema, "Poseida") ...
Exxel Pharma to Participate in the Virtual Investor Lunch Break: The Exxel Opportunity
The Joplin Globe· 14 hours agoLive webcast with Soren Mogelsvang, PhD, Chief Executive Officer of Exxel Pharma, on Wednesday, May 8th at 12 PM ET
Poolbeg Pharma confirms US patent grant
Proactive Investors· 21 hours agoPoolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) has been granted a full patent in the United States for its drug candidate POLB 001, aimed at treating and...
Janssen adopts J&J name as part of global rebranding effort
Pharmaceutical Technology via Yahoo Finance· 13 hours agoJ&J has not been the only big pharma to recently modernise and tighten its brand identity. Sanofi...
Jacobio Pharma Announced its KRAS G12C inhibitor reached the primary endpoint
WTRF Wheeling· 1 day agoJacobio Pharma (1167.HK) announced that the data from the Phase II registrational study of the KRAS G12C inhibitor glecirasib were offically reported at the April ASCO Plenary ...
Poolbeg Pharma PLC Announces Significant POLB 001 Patent Granted in USA
Digital Journal· 22 hours agoEnquiries Poolbeg Pharma Plc Jeremy Skillington, CEO Ian O'Connell, CFO +44 (0) 207 183 1499 Cavendish Capital Markets Ltd (Nominated...
Geodis obtains IATA CEIV Pharma certification for its Copenhagen hub - The Loadstar
The Loadstar· 3 days agoGEODIS now has a total of 28 CEIV Pharma certified sites across its global network in the Americas,...
Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in...
WFRV 5 Green Bay· 2 days ago(Nasdaq: ALNY), the leading RNAi therapeutics company, announced today a further expansion...